NovoCure LimitedNVCRNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
8.86%
↑ 102% above average
Average (39q)
-459.52%
Historical baseline
Range
High:297.22%
Low:-13871.59%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 8.86% |
| Q2 2025 | -4.37% |
| Q1 2025 | 40.19% |
| Q4 2024 | -97.26% |
| Q3 2024 | 4.51% |
| Q2 2024 | 19.06% |
| Q1 2024 | 19.72% |
| Q4 2023 | 11.21% |
| Q3 2023 | 7.05% |
| Q2 2023 | -4.00% |
| Q1 2023 | -40.19% |
| Q4 2022 | -74.63% |
| Q3 2022 | -16.49% |
| Q2 2022 | -2521.34% |
| Q1 2022 | 96.56% |
| Q4 2021 | -173.60% |
| Q3 2021 | 30.44% |
| Q2 2021 | -13871.59% |
| Q1 2021 | -100.73% |
| Q4 2020 | -19.50% |
| Q3 2020 | 125.28% |
| Q2 2020 | 297.22% |
| Q1 2020 | -2324.34% |
| Q4 2019 | -96.06% |
| Q3 2019 | 222.32% |
| Q2 2019 | 119.55% |
| Q1 2019 | 29.39% |
| Q4 2018 | -65.15% |
| Q3 2018 | 25.96% |
| Q2 2018 | 44.11% |
| Q1 2018 | -181.34% |
| Q4 2017 | 23.87% |
| Q3 2017 | 61.89% |
| Q2 2017 | -16.13% |
| Q1 2017 | 25.19% |
| Q4 2016 | 36.75% |
| Q3 2016 | 24.09% |
| Q2 2016 | -16.59% |
| Q1 2016 | -4.35% |
| Q4 2015 | -26.27% |